Albunex: A Safe and Effective Commercially Produced Agent for Myocardial Contrast Echocardiography
- 1 January 1989
- journal article
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 2 (1), 48-52
- https://doi.org/10.1016/s0894-7317(89)80028-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Myocardial contrast echocardiography in humans. II. Assessment of coronary blood flow reserveJournal of the American College of Cardiology, 1988
- Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: A major advantage in the imaging of regional myocardial perfusionJournal of the American College of Cardiology, 1988
- Effects of selectively altering collateral driving pressure on regional perfusion and function in occluded coronary bed in the dog.Circulation Research, 1987
- The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography.Circulation, 1987
- Echocardiographic contrast agents: Effect of microbubbles and carrier solutions on left ventricular contractilityJournal of the American College of Cardiology, 1987
- Myocardial contrast echocardiography in humans: I. Safety—A comparison with routine coronary arteriographyJournal of the American College of Cardiology, 1986
- Contrast echocardiography in acute myocardial ischemia. II. The effect of site of injection of contrast agent on the estimation of area at risk for necrosis after coronary occlusionJournal of the American College of Cardiology, 1985
- Functional and pathologic effects of multiple echocardiographic contrast injections on the myocardium, brain and kidneyJournal of the American College of Cardiology, 1985
- Contrast echocardiography in acute myocardial ischemia: I. In vivo determination of total left ventricular “area at risk”Journal of the American College of Cardiology, 1984
- Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion.Circulation, 1984